The use of interferon for emergency prophylaxis of marburg hemorrhagic fever in monkeys

Bull Exp Biol Med. 2001 Jul;132(1):686-8. doi: 10.1023/a:1012540614713.

Abstract

The possibility of emergency prophylaxis of Marburg hemorrhagic fever with leukocytic and recombinant interferons was studied in experiments on Cercopithecus aethiops. None of the agents protected monkeys from the action of lethal doses of Marburg virus. Recombinant interferon-alpha(2)administered according to the emergency prophylaxis schedule prolonged the mean life-span of monkeys injected with Marburg virus in doses of 100 and 1000 LD50 by 1.9 and 6.1 days, respectively.

MeSH terms

  • Acute Disease
  • Animals
  • Blood / virology
  • Body Temperature
  • Chlorocebus aethiops
  • Guinea Pigs
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / immunology
  • Interferon-alpha / therapeutic use*
  • Marburg Virus Disease / immunology
  • Marburg Virus Disease / prevention & control*
  • Marburgvirus / physiology
  • Recombinant Proteins
  • Survival
  • Viremia

Substances

  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins